DCAT Value Chain Insights’ Production to Prescription
DCAT Value Chain Insights' Production to Prescription podcast, presented by the Drug, Chemical & Associated Technologies Association (DCAT), features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.
Episodes
Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, an important barometer of the financial health of the sectors, has been under pressure with macro factors in the US on tariffs, tax & monetary policy, and drug pricing reforms contributing to uncertainty. But will the tide turn?
Featuring Arda ...
As evolving US trade policy looms, what are the demand–supply fundamentals now in the global market for active pharmaceutical ingredients (APIs)? A look at the demand side—size, growth rates, and trends— and the supply side—key segments for global API manufacturing and its geographic dispersion. Plus, examining the impact of potential tariffs on manufacturing and supply chains.
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing up or down? Are biopharma companies outsourcing more or less? Plus the impact on evolving trade policy on biomanufacturing supply chains.
Featuring: Eric Langer, MBA, Managing Partner & President, BioPlan...
How are supply and demand shaping up for sterile manufacturing and aseptic fill–finish in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such as GLP-1 agonist impact market fundamentals.
Featuring Ian Tzeng, Managing Director and Partner, L.E.K. Consulting, where he focuses on healthcare and life sciences, including pharmaceuticals, vaccines, and leads L.E.K.’s Pharmaceut...
What will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in product-specific supply chains for sterile injectables and antibody drug conjugates. And the latest on how companies are advancing upstream supplier risk monitoring and predictive risk planning, including through digitalization and AI.
Featuring: Derron Stark, EY-P...
What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights takes an inside look. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Major trends in parenteral drug development
- Long peptides ...
As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Baxter
- Samsung Biologics
- Lotte Biologics
- Fujifilm Diosynth Biote...
As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an inside look on what is on the industry’s radar. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Baxter
- Large-scale biomanufacturing expansions continue
- Sams...
The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages and secure supply chains. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Proposed reforms
- Security of supply and supply-chain reforms
- ...
Increased demand in biologic-based drug development is a key factor driving demand for parenteral drug manufacturing. What are key trends and expansions by CDMO/CMOs in parenteral drug manufacturing? DCAT Value Chain Insights rounds up the latest developments among CDMO/CMOs. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Recent expansi...
What are noteworthy trends in drug delivery and drug-product development in key dosage forms: solid dosage and parenteral drugs? A look at key technology advances and recent new drug approvals. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Recent trends: new drug approvals
- Technology advances
- Enable Injections’ on-body subcutaneous drug-delivery sys...
Growth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? DCAT Value Chain Insights rounds up the latest investments. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- A roundup of recent investments in HPAPI manufacturing
- WuXi STA
- MilliporeSigma
- Piramal Pharma Solutions
- Cambrex
- HAS He...
A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Sustainability and the bio/pharma supply chain
- Key finding: External stakeholders drive efforts
- Key finding: Supply-chain sustainability lags inter...
Capital investments are ramping up in biomanufacturing, which continues to be an active area for CDMOs/CMOs in both traditional biologics and new modalities. Which companies are expanding? For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- A roundup of expansion activity
- Fujifilm Diosynth Biotechnologies
- Samsung Biologics
- Lonza
- Boehringer Ingelheim
- Thermo F...
A DCAT Week program brings together leading Bio/Pharma executives to offer their perspectives on how Bio/Pharma companies and their suppliers are adjusting supply practices now and in the near term. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Supply-chain challenges and solutions (1:13)
Sponsor: LGM Pharma
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Parenteral drugs have accounted for between 40% and 50% of new drug approvals over the past five years. CDMOs/CMOs continue to expand. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Active area of investment (1:13)
- Baxter BioPharma Solutions (1:25)
- PCI Pharma Services (2:07)
- Alcami (3:22)
- Catalent (4:31)
- Vetter (5:47)
- Thermo Fisher Scientific (6:41)
- Grand...
Escalating energy prices are impacting global manufacturing and supply chains. In the EU, leaders are proposing measures to alleviate pricing pressures. What’s the plan?
Key topics: (see Chapter Markers)
- Economic recovery brings pricing pressures
- Rising energy costs and the bio/pharma manufacturing value chain
- Rising energy costs: call for action in the EU
- Ripple effect throughout industrial supply chains
- Actions pro...
Which modality, small molecules or biologics, leads among the top-selling products? A look at the top-selling products industry-wide and blockbusters from select leading bio/pharma companies provides the answer. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Modality of top-selling products
- New drug approvals: small molecules versus biologics
- Potential blockbusters: small molecules and bio...
Drug delivery is important not only for ensuring bioavailability for therapeutic benefit but also for product differentiation and market success. DCAT Value Chain Insights highlights technology advances in drug delivery for injectable and solid-dosage drugs and other products from recent start-ups, partnering deals, and mergers and acquisitions. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers...
What have been the key developments in 2021 thus far in the CDMO market? In this podcast we take a look at the increasing participation by CDMOs in COVID-19 vaccine manufacturing and robust mergers and acquisition activity that have marked the first half of 2021. What are the implications, and what can be expected going forward? For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- CDMOs and CO...
Popular Podcasts
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The latest news in 4 minutes updated every hour, every day.
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com